1313427208300564480

Today we reported additional, positive data from our Phase 3 study of our investigational cell therapy, omidubicel. We are grateful to all the patients, investigators and study teams who participated. Learn more here: https://t.co/EYH7DEV4sn #InspiredToCure https://t.co/b4c7ZbspWe

Send us a message